AAAAAA

   
Results: 1-21 |
Results: 21
Using HIV-1 sequence variability to explore virus biology (vol 76, pg 137,2001)
Authors: McGrath, KM Hoffman, NG Resch, W Nelson, JAE Swanstrom, R
Citation: Km. Mcgrath et al., Using HIV-1 sequence variability to explore virus biology (vol 76, pg 137,2001), VIRUS RES, 80(1-2), 2001, pp. 125-125
Using HIV-1 sequence variability to explore virus biology
Authors: McGrath, KM Hoffman, NG Resch, W Nelson, JAE Swanstrom, R
Citation: Km. Mcgrath et al., Using HIV-1 sequence variability to explore virus biology, VIRUS RES, 76(2), 2001, pp. 137-160
Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks
Authors: Resch, W Hoffman, N Swanstrom, R
Citation: W. Resch et al., Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks, VIROLOGY, 288(1), 2001, pp. 51-62
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics
Authors: Resch, W Parkin, N Stuelke, EL Watkins, T Swanstrom, R
Citation: W. Resch et al., A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics, P NAS US, 98(1), 2001, pp. 176-181
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity
Authors: Gorry, PR Bristol, G Zack, JA Ritola, K Swanstrom, R Birch, CJ Bell, JE Bannert, N Crawford, K Wang, H Schols, D De Clercq, E Kunstman, K Wolinsky, SM Gabuzda, D
Citation: Pr. Gorry et al., Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity, J VIROLOGY, 75(21), 2001, pp. 10073-10089
Proteolytic processing of the P2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation
Authors: Shehu-Xhilaga, M Kraeusslich, HG Pettit, S Swanstrom, R Lee, JY Marshall, JA Crowe, SM Mak, J
Citation: M. Shehu-xhilaga et al., Proteolytic processing of the P2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation, J VIROLOGY, 75(19), 2001, pp. 9156-9164
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses
Authors: Freel, SA Williams, JM Nelson, JAE Paton, LL Fiscus, SA Swanstrom, R Shugars, DC
Citation: Sa. Freel et al., Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses, J VIROLOGY, 75(10), 2001, pp. 4936-4940
Protease inhibitor resistance in HIV-1 infection
Authors: Resch, W Swanstrom, R
Citation: W. Resch et R. Swanstrom, Protease inhibitor resistance in HIV-1 infection, REV MED MIC, 11(4), 2000, pp. 211-221
Analysis of HIV type 1 reverse transcriptase: Comparing sequences of viralisolates with mutational data
Authors: Wrobel, JA Conrad, MJ Bloedon, E Swanstrom, R Hutchison, CA
Citation: Ja. Wrobel et al., Analysis of HIV type 1 reverse transcriptase: Comparing sequences of viralisolates with mutational data, AIDS RES H, 16(18), 2000, pp. 2049-2054
Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance (vol 86, pg 145, 2000)
Authors: Swanstrom, R Eron, J
Citation: R. Swanstrom et J. Eron, Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance (vol 86, pg 145, 2000), PHARM THERA, 88(1), 2000, pp. 91-91
Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance
Authors: Swanstrom, R Erona, J
Citation: R. Swanstrom et J. Erona, Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance, PHARM THERA, 86(2), 2000, pp. 145-170
No evidence for naturally occurring mutations resistant to HIV-1 reverse-transcriptase inhibitors among South African HIV-1 subtype C isolates
Authors: Morris, L Bredell, H van Harmelen, J Ping, LH Pasqual, A Ramjee, G Karim, SA Gray, G McIntyre, J Maartens, G Swanstrom, R Williamson, C
Citation: L. Morris et al., No evidence for naturally occurring mutations resistant to HIV-1 reverse-transcriptase inhibitors among South African HIV-1 subtype C isolates, S AFR J SCI, 96(7), 2000, pp. 369-370
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles (vol 74, pg 371, 2000)
Authors: Davis, NL Caley, IJ Brown, KW Betts, MR Irlbeck, DM McGrath, KM Connell, MJ Montefiori, DC Frelinger, JA Swanstrom, R Johnson, PR Johnston, RE
Citation: Nl. Davis et al., Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles (vol 74, pg 371, 2000), J VIROLOGY, 74(7), 2000, pp. 3430-3430
Effects of genital tract inflammation on human immunodeficiency virus type1 V3 populations in blood and semen
Authors: Ping, LH Cohen, MS Hoffman, I Vernazza, P Seillier-Moiseiwitsch, F Chakraborty, H Kazembe, P Zimba, D Maida, M Fiscus, SA Eron, JJ Swanstrom, R Nelson, JAE
Citation: Lh. Ping et al., Effects of genital tract inflammation on human immunodeficiency virus type1 V3 populations in blood and semen, J VIROLOGY, 74(19), 2000, pp. 8946-8952
Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection
Authors: Nelson, JEA Baribaud, F Edwards, T Swanstrom, R
Citation: Jea. Nelson et al., Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection, J VIROLOGY, 74(18), 2000, pp. 8494-8501
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
Authors: Davis, NL Caley, IJ Brown, KW Betts, MR Irlbeck, DM McGrath, KM Connell, MJ Montefiori, DC Frelinger, JA Swanstrom, R Johnson, PR Johnston, RE
Citation: Nl. Davis et al., Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles, J VIROLOGY, 74(1), 2000, pp. 371-378
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359
Authors: Gulick, RM Hu, XJ Fiscus, SA Fletcher, CV Haubrich, R Cheng, HL Acosta, E Lagakos, SW Swanstrom, R Freimuth, W Snyder, S Mills, C Fischl, M Pettinelli, C Katzenstein, D
Citation: Rm. Gulick et al., Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359, J INFEC DIS, 182(5), 2000, pp. 1375-1384
The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance
Authors: Vaillancourt, M Irlbeck, D Smith, T Coombs, RW Swanstrom, R
Citation: M. Vaillancourt et al., The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance, AIDS RES H, 15(4), 1999, pp. 355-363
The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999)
Authors: Vaillancourt, M Irlbeck, D Smith, T Coombs, RW Swanstrom, R
Citation: M. Vaillancourt et al., The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999), AIDS RES H, 15(10), 1999, pp. 949-949
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy
Authors: Caley, IJ Betts, MR Davis, NL Swanstrom, R Frelinger, JA Johnston, RE
Citation: Ij. Caley et al., Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy, VACCINE, 17(23-24), 1999, pp. 3124-3135
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
Authors: Ping, LH Nelson, JAE Hoffman, IF Schock, J Lamers, SL Goodman, M Vernazza, P Kazembe, P Maida, M Zimba, D Goodenow, MM Eron, JJ Fiscus, SA Cohen, MS Swanstrom, R
Citation: Lh. Ping et al., Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants, J VIROLOGY, 73(8), 1999, pp. 6271-6281
Risultati: 1-21 |